Skip to search formSkip to main contentSkip to account menu

CX 01

Known as: CX-01, CX01 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

2-O, 3-O Desulfated Heparin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The Use of Myelinating Cultures as a Screen of Glycomolecules for CNS Repair
In vitro cell-based assays have been fundamental in modern drug discovery and have led to the identification of novel… 
2019
2019
CX-01 Heparin Derivative Investigated for Older Patients With AML
A randomized phase II trial investigated whether adding CX-01, a low anticoagulant heparin derivative, to standard care improves… 
Review
2019
Review
2019
P36 SENTIX – a prospective cohort international study on sentinel lymph node biopsy without pelvic lymph node dissection in cervical cancer patients: central quality control of SLN pathological…
Introduction/Background The quality of pathological assessment is of pivotal importance in the management of cervical cancer… 
2018
2018
CX-01, an inhibitor of CXCL12/CXCR4 axis and of platelet factor 4 (PF4), with azacitidine (AZA) in patients with hypomethylating agent (HMA) refractory AML and MDS.
7027Background: Outcomes are poor for older patients with AML and MDS who progress on HMAs. Blocking the CXCL12/CXCR4 axis may be… 
2016
2016
CX-01, a Low Anticoagulant Heparin, May Enhance Count Recovery and Treatment Efficacy in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) therapy is associated with pancytopenia and with a high failure rate due to resistant leukemia stem… 
2003
2003
Ethical Marketing for Competitive Advantage on the Internet
Dr. Claire Gauzente is Assistant Professor of Marketing and Organization at the University of Angers, UFR de Droit, Economie et… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)